Perampanel as add-on therapy in epilepsies with known etiology: A single center experience with long-term follow-up

We report a retrospective monocentric study performed on 63 patients affected by epilepsy with known etiology, receiving perampanel as add-on therapy with at least 12-month follow-up. The purpose of our study was to evaluate efficacy and tolerability of perampanel in this group of epilepsies. Patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Nilo, Annacarmen, Pauletto, Giada, Gigli, Gian Luigi, Vogrig, Alberto, Dolso, Pierluigi, Valente, Mariarosaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797501/
https://www.ncbi.nlm.nih.gov/pubmed/33458643
http://dx.doi.org/10.1016/j.ebr.2020.100393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797501/
https://www.ncbi.nlm.nih.gov/pubmed/33458643
http://dx.doi.org/10.1016/j.ebr.2020.100393

Ejemplares similares